About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD10.3356723130127.0684
Domestic EquitiesABBOTT INDIA LTD5.89222795372.4402
Domestic EquitiesDIVI LABORATORIES LTD5.833712060071.7208
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD5.3900126172766.2659
Domestic EquitiesMAX HEALTHCARE INSTITUTE LTD5.140565674663.1987
Domestic EquitiesCIPLA LTD5.104351260462.7530
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD4.25347048452.2921
Domestic EquitiesRAINBOW CHILDRENS MEDICARE LTD4.230144713352.0060
Domestic EquitiesMANKIND PHARMA LTD3.573721904543.9360
Domestic EquitiesBAYER CROPSCIENCE LTD3.50759282443.1223
Domestic EquitiesDR REDDYS LABORATORIES LTD3.445933759642.3649
Domestic EquitiesLUPIN LTD3.176616877839.0535
Domestic EquitiesFORTIS HEALTHCARE LTD3.168548998638.9539
Domestic EquitiesMETROPOLIS HEALTHCARE LTD3.017285470437.0942
Domestic EquitiesDR. LAL PATH LABS LTD2.689825203033.0689
Domestic EquitiesSYNGENE INTERNATIONAL LTD2.642283313232.4838
Domestic EquitiesSAI LIFE SCIENCES LTD2.577232597831.6851
Domestic EquitiesALKEM LABORATORIES LTD2.45125687030.1354
Domestic EquitiesJ.B.CHEMICALS & PHARMACEUTICALS LTD2.404314318329.5587
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD2.143211541326.3488
Domestic EquitiesNEULAND LABORATORIES LTD2.08022126425.5742
Domestic EquitiesAJANTA PHARMA LTD2.04048942625.0849
Domestic EquitiesGLOBAL HEALTH LTD2.005425653224.6553
Domestic EquitiesFDC LTD1.839070411922.6093
Domestic EquitiesSANOFI INDIA LTD1.70406526820.9491
Domestic EquitiesVIJAYA DIAGNOSTIC CENTRE LTD1.407120082317.2989
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL SCIENCES LTD1.340726521616.4832
Domestic EquitiesAUROBINDO PHARMA LTD1.199011300914.7409
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.10143208613.5409
Domestic EquitiesCORONA REMEDIES LTD0.7490591819.2086
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD0.6969178558.5683
Domestic EquitiesPI INDUSTRIES LTD0.6273283657.7119
Domestic EquitiesHDFC LIFE INSURANCE CO. LTD0.62441299717.6761
Domestic EquitiesTATA CHEMICALS LTD0.50431062976.1998
Domestic EquitiesSUMITOMO CHEMICAL INDIA LTD0.39101318884.8067
Domestic EquitiesJUBILANT PHARMOVA LTD0.3379508884.1548
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD0.0666201290.8183
Domestic EquitiesIPCA LABORATORIES LTD0.00322490.0399
Total 99.6950 1225.6717
Cash & Cash Equivalents and Net AssetsA) REPO0.2612 3.2109
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET0.0439 0.5392
Total 0.3050 3.7501
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.